Timigutuzumab Biosimilar - Research Grade

Human

ERBB2ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P04626;P04626;P70424

Blue ice

HER2 (ERBB2) is a receptor tyrosine kinase amplified in breast, gastric, and other cancers and one of the most studied oncogenic targets. This product is a research-grade, unconjugated analog of timigutuzumab, a recombinant anti-HER2 monoclonal antibody for research use only. Manufactured to in vivo standards with low endotoxin, it is available in scalable milligram to gram quantities for bulk and high-throughput laboratories. The antibody suits HER2-binding functional assays, in vitro signaling and ADCC screens, and in vivo tumor models of HER2-driven cancer. Reproducible, high-purity preparation supports reliable results across repeated and large-scale experiments.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks